Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Martin Gauthier

11PUBLICATIONS

23CO-AUTHORS

Tumour immunologyCardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Aug 24, 2023

Vacuolated lymphocytes as initial presentation of angioimmunoblastic T-cell lymphoma.

Martin Gauthier, David Dombrowski, Inès Vergnolle

|Jul 18, 2022

Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR-ABL1 detection failure using RT-MLPA (positive RT-qPCR).

Lucie Coster, Véronique Mansat-De Mas, Laetitia Largeaud

|May 26, 2022

Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system.

Clémentine Vabre, Yoann Zelmat, Martin Gauthier

|Mar 19, 2022

Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study.

Cécile Conte, Flora Vayr, Marie-Christelle Pajiep

|Mar 07, 2022

Look beyond the plasma cells in immunocompromised patients.

Romain Lécuyer, Barnabé Daniau, Imène Guelib

|Mar 05, 2022

"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies.

Léopoldine Lapierre, Charlotte Syrykh, Laetitia Largeaud

Pageof 2

Frequent Collaborators

2 joint publications

Maryse Lapeyre-Mestre

2 joint publications

François Vergez

1 joint publications

Pierre-Luc Mouchel

1 joint publications

Cédric Rossi

1 joint publications

David Tonnelet

1 joint publications

Eric Durot

1 joint publications

Caroline Besson

1 joint publications

Katell Le Du

1 joint publications

Ghandi Damaj

1 joint publications

Pierre Decazes

Frequent Collaborators

2 joint publications

Maryse Lapeyre-Mestre

2 joint publications

François Vergez

1 joint publications

Pierre-Luc Mouchel

1 joint publications

Cédric Rossi

Top Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on : Aug 23, 2024

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos

Top Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on : Aug 23, 2024

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos